Biomarker Validation Analysis & Regulatory Documentation
Validate biomarkers and generate FDA/EMA-ready regulatory documentation
What You Can Do
You can systematically analyze biomarker discovery cohorts, interpret statistical associations within biological context, and generate regulatory-compliant validation reports. This skill bridges raw data analysis output (p-values, hazard ratios, ROC curves) and publishable biomarker evidence, helping you prepare biomarker qualification packages and clinical development submissions without manual report compilation.
Features
Contextualizes p-values, effect sizes, and confidence intervals within disease biology and mechanistic frameworks
Generates FDA/EMA-aligned Methods, Results, and biomarker qualification sections ready for submissions
Documents assay performance, cohort characteristics, and validation criteria across multiple platforms (RNA-seq, proteomics, immunohistochemistry)
Integrates findings from different assay technologies into unified, coherent biomarker evidence narratives
Produces executive briefs and technical reports for clinical teams and regulatory interactions
Validates documentation against FDA guidance documents and ICH guidelines for biomarker qualification
Structures findings into manuscript-quality Methods and Results sections with appropriate statistical reporting
Example Output
Example 1: Statistical Interpretation Output
- Input: RNA-seq data showing 2.3-fold upregulation (p=0.008, 95% CI: 1.4–3.8) in 45 responders vs. 52 non-responders
- Output: "The biomarker demonstrated robust differential expression (2.3-fold, p=0.008) with tight confidence intervals supporting biological significance. Effect size and sample size provide 87% power for detection, consistent with prognostic biomarker qualification thresholds."
Example 2: Regulatory Document Section
- Input: Proteomics assay sensitivity/specificity data across 3 cohorts
- Output: Fully formatted FDA-style analytical validity section with platform description, assay performance metrics, analytical concordance tables, and reference to qualification guidance
Example 3: Quality Control Checklist
- Input: Cohort demographics, inclusion/exclusion criteria, assay protocols
- Output: Structured QC report confirming homogeneity, documenting potential confounders, and validating compliance with predefined analysis plan
What's Included
- SKILL.md instruction file with complete biomarker validation workflow:
- Regulatory Documentation Template: FDA/EMA-compliant sections for biomarker qualification packages
- Statistical Interpretation Framework: Guide for contextualizing effect sizes and p-values within biological relevance
- Quality Control Checklist: Validation criteria for cohort design, assay platform performance, and analytical concordance
- Multi-Platform Synthesis Worksheet: Structured approach for integrating RNA-seq, proteomics, immunohistochemistry, and other modalities into unified evidence
Who It's For
- Bioinformatics Scientists — Analyzing biomarker discovery and validation cohorts for clinical development
- Regulatory Affairs Specialists — Preparing biomarker qualification submissions and FDA interactions
- Clinical Development Managers — Synthesizing biomarker evidence for program strategy and go/no-go decisions
- Translational Researchers — Bridging bench-to-clinic biomarker pipelines with publication-ready documentation
- Biostatisticians — Documenting interpretation and clinical context around statistical findings
Best For
- Generating regulatory-compliant biomarker qualification packages for FDA/EMA submission
- Drafting Methods and Results sections for biomarker-focused manuscripts and clinical publications
- Synthesizing multi-platform assay data (RNA-seq, proteomics, IHC) into unified biomarker evidence narratives
- Creating quality control and analytical validity reports for clinical development teams
- Interpreting statistical associations through mechanistic and disease biology frameworks
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w